Australia markets closed

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
8,721.72-5.28 (-0.06%)
As of 10:49AM GMT. Market open.
Currency in GBp

Valuation measures4

Market cap (intra-day) 126.92B
Enterprise value 145.65B
Trailing P/E 97.60
Forward P/E 16.56
PEG ratio (5-yr expected) 0.97
Price/sales (ttm)4.51
Price/book (mrq)4.22
Enterprise value/revenue 4.44
Enterprise value/EBITDA 18.38

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 314.72%
S&P500 52-week change 321.05%
52-week high 39,523.00
52-week low 36,499.80
50-day moving average 38,527.36
200-day moving average 38,405.17

Share statistics

Avg vol (3-month) 31.96M
Avg vol (10-day) 31.82M
Shares outstanding 51.55B
Implied shares outstanding 6N/A
Float 81.49B
% held by insiders 10.24%
% held by institutions 149.87%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.02
Forward annual dividend yield 42.32%
Trailing annual dividend rate 33.70
Trailing annual dividend yield 30.04%
5-year average dividend yield 43.37
Payout ratio 4252.65%
Dividend date 3N/A
Ex-dividend date 412 Aug 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 Sept 2021


Profit margin 4.48%
Operating margin (ttm)9.80%

Management effectiveness

Return on assets (ttm)2.35%
Return on equity (ttm)5.48%

Income statement

Revenue (ttm)32.82B
Revenue per share (ttm)24.16
Quarterly revenue growth (yoy)50.00%
Gross profit (ttm)21.37B
Net income avi to common (ttm)1.47B
Diluted EPS (ttm)79.30
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.15B
Total cash per share (mrq)4.78
Total debt (mrq)34.39B
Total debt/equity (mrq)86.16
Current ratio (mrq)1.13
Book value per share (mrq)26.57

Cash flow statement

Operating cash flow (ttm)6.34B
Levered free cash flow (ttm)-1.39B